Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA

Rang in aandelen #35791
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Aandeelprijs
$0.016
Laatst gesynchroniseerd: 2024-03-11
Marktkapitalisatie
$3.27M
Verandering (1 dag)
-5.33%
Verandering (1 jaar)
5,233.33%
Land
US
Handel Invitae Corporation (NVTA)

Categorie

Healthcare
Dividendrendementgeschiedenis voor Invitae Corporation (NVTA)
Het dividendrendement (TTM) van Invitae Corporation (aandelsymbool: NVTA) per 2021-12-31 is: 0.00%
Gemiddeld dividendrendement over de afgelopen 5 jaar: 0.00%
Dividendrendementgeschiedenis van Invitae Corporation (NVTA) van 2012 tot 2026
Dividendrendement aan het einde van elk jaar (TTM)
Jaar Dividendrendement Wijzigen
2026 (TTM) 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
Dividendrendementen (TTM) van vergelijkbare bedrijven of concurrenten